199 related articles for article (PubMed ID: 12107848)
1. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
Connolly EM; Harmey JH; O'Grady T; Foley D; Roche-Nagle G; Kay E; Bouchier-Hayes DJ
Br J Cancer; 2002 Jul; 87(2):231-7. PubMed ID: 12107848
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic activity of a cyclooxygenase-2 inhibitor.
Roche-Nagle G; Connolly EM; Eng M; Bouchier-Hayes DJ; Harmey JH
Br J Cancer; 2004 Jul; 91(2):359-65. PubMed ID: 15213717
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
Rozic JG; Chakraborty C; Lala PK
Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
Majumder M; Xin X; Liu L; Girish GV; Lala PK
Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
[TBL] [Abstract][Full Text] [Related]
8. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer.
Yao M; Song DH; Rana B; Wolfe MM
Br J Cancer; 2002 Aug; 87(5):574-9. PubMed ID: 12189559
[TBL] [Abstract][Full Text] [Related]
9. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
Kundu N; Fulton AM
Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic implantation of a colon cancer xenograft induces high expression of cyclooxygenase-2.
Shoji T; Konno H; Tanaka T; Sakaguchi T; Sunayama K; Baba M; Kamiya K; Ohta M; Kaneko T; Igarashi A; Nakamura S
Cancer Lett; 2003 Jun; 195(2):235-41. PubMed ID: 12767532
[TBL] [Abstract][Full Text] [Related]
12. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
Khoo NK; Chan FP; Saarloos MN; Lala PK
Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
[TBL] [Abstract][Full Text] [Related]
14. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
[TBL] [Abstract][Full Text] [Related]
15. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
Gately S; Kerbel R
Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
[TBL] [Abstract][Full Text] [Related]
17. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
Wallace JL; Chapman K; McKnight W
Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
[TBL] [Abstract][Full Text] [Related]
19. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.
Zhang Z; DuBois RN
Oncogene; 2001 Jul; 20(33):4450-6. PubMed ID: 11494140
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma.
Diperna CA; Bart RD; Sievers EM; Ma Y; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1129-33. PubMed ID: 14566258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
